Recursion Pharmaceuticals
operating company · company profileSalt Lake City · Seed · 18 people tracked
Find your way into Recursion Pharmaceuticals
Sign up to find every way you can get introduced to Recursion Pharmaceuticals
- Your email: who you already know at Recursion Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Recursion Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Recursion is a biotechnology company that combines science and technology to decode biology and develop new medicines, operating a drug discovery platform supported by life scientists and computational experts.
Source: firm website, verified Oct 2, 2026.
Team · 18 people
from the firm's websiteFrequently asked questions
- What stage does Recursion Pharmaceuticals invest at?
- Recursion Pharmaceuticals invests at the Seed stage.
- What sectors does Recursion Pharmaceuticals focus on?
- Recursion Pharmaceuticals focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech.
- Where is Recursion Pharmaceuticals located?
- Recursion Pharmaceuticals is headquartered in Salt Lake City, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
















.jpeg)